📖 Free full textPeer-ReviewedPubMedResearch ArticleTherapeuticCancer · 2026
HERMES trial supports shortened SBRT schedule without added toxicity for patients with prostate cancer.
Lawrence L.
Identifiers
PubMed ID: 42676121
DOI: 10.1002/cncr.70538
Lawrence L.
Request brochure
Tell us who you are and we’ll send the full product brochure to your institutional email after a quick review. We respond within one working day (Mon–Fri, 9:30–18:30 IST).
A Saxsons sales engineer will review your request and send the brochure to your institutional email within one working day. You may receive a verification call before processing.